The EU-funded CLARIFY Project (Cancer Long Survivor Artificial Intelligence Follow-up) will identify the risk factors that affect patient´s health status after oncological treatment.
Clarify will combine the expertise of partners from 5 different European countries to develop an innovative platform that will support the decision-making of medical doctors to improve the care of cancer survivors.
The consortium, is composed of 12 partners: Hospital Puerta de Hierro-Servicio Madrileno de Salud(Spain); Universidad Politécnica de Madrid (Spain), Technische Informationsbibliothek -TIB- (Germany), Holos Soluções Avançadas em Tecnologias de Informação, (Portugal); National University of Ireland (Ireland), University College London, (United Kingdom), University College Dublin (Ireland), Accenture Global Solutions (Ireland); Grupo Oncológico para el Tratamiento de las Enfermedades Linfoides-GOTEL- (Spain); Stelar Security Technology (Germany), Grupo Español de Investigación en Cáncer de Pulmón- GECP- (Spain); Kronohealth (Spain).
Clarify project is funded by the European Union with 5 million euros, under the Horizon 2020 program (under grant agreement No 875160).
Follow us online:
CLARIFY website: http://www.clarify2020.eu